Funds holding “Johnson & Johnson”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
38 positions across 38 funds, 3 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| BME BlackRock Health Sciences Trust Healthcare | Johnson & Johnson | 478160104 | EC | 7.79% | $44.6M | Jun 30, 2026 | full (152 positions) |
| BMEZ BlackRock Health Sciences Term Trust Healthcare | Johnson & Johnson | 478160104 | EC | 3.42% | $37M | Jun 30, 2026 | full (170 positions) |
| BOE BlackRock Enhanced Global Dividend Trust Global Equity | Johnson & Johnson | 478160104 | EC | 2.45% | $17.9M | Jun 30, 2026 | full (129 positions) |
| BDJ BlackRock Enhanced Equity Dividend Trust U.S. Equity | Johnson & Johnson | 478160104 | EC | 2.34% | $42.1M | Jun 30, 2026 | full (179 positions) |
| IGD Voya Global Equity Dividend & Premium Opportunity Fund Global Equity | JOHNSON & JOHNSON | 478160104 | EC | 1.74% | $8.5M | May 31, 2026 | full (249 positions) |
| IGA Voya Global Advantage & Premium Opportunity Fund Multi-Asset | JOHNSON & JOHNSON | 478160104 | EC | 1.74% | $2.8M | May 31, 2026 | full (249 positions) |
| GRF Eagle Capital Growth Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | 1.71% | $780K | Jun 30, 2026 | full (26 positions) |
| JCE Nuveen Core Equity Alpha Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | 1.69% | $5.1M | Jun 30, 2026 | full (144 positions) |
| ETY Eaton Vance Tax-Managed Diversified Equity Income Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | 1.59% | $39.8M | Jul 31, 2026 | full (58 positions) |
| EOI Eaton Vance Enhanced Equity Income Fund Covered Call / Option Income | Johnson & Johnson | 478160104 | EC | 1.58% | $13.7M | Jun 30, 2026 | full (108 positions) |
| ETJ Eaton Vance Risk-Managed Diversified Equity Income Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | 1.55% | $9.6M | Jun 30, 2026 | full (59 positions) |
| NIE Virtus Equity & Convertible Income Fund Convertible Securities | JOHNSON & JOHNSON | 478160104 | EC | 1.47% | $11.5M | Jul 31, 2026 | full (164 positions) |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund Covered Call / Option Income | Johnson & Johnson | 478160104 | EC | 1.44% | $41.5M | Jun 30, 2026 | full (556 positions) |
| CRF Cornerstone Total Return Fund Multi-Asset | JOHNSON & JOHNSON | 478160104 | EC | 1.43% | $15.1M | Jun 30, 2026 | full (101 positions) |
| CLM Cornerstone Strategic Investment Fund Multi-Asset | JOHNSON & JOHNSON | 478160104 | EC | 1.39% | $27.7M | Jun 30, 2026 | full (113 positions) |
| CSQ Calamos Strategic Total Return Fund Multi-Asset | Johnson & Johnson | 478160104 | EC | 1.14% | $55.7M | Jul 31, 2026 | full (820 positions) |
| ETB Eaton Vance Tax-Managed Buy-Write Income Fund Covered Call / Option Income | Johnson & Johnson | 478160104 | EC | 1.14% | $5.6M | Jun 30, 2026 | full (133 positions) |
| SCD LMP Capital & Income Fund U.S. Equity | JOHNSON & JOHNSON | 478160104 | EC | 1.08% | $5.5M | May 29, 2026 | full (169 positions) |
| GRX Gabelli Healthcare & WellnessRx Trust Healthcare | JOHNSON & JOHNSON | 478160104 | EC | 1.08% | $2.5M | Jun 30, 2026 | full (195 positions) |
| NMAI Nuveen Multi-Asset Income Fund Multi-Asset | Johnson & Johnson | 478160104 | EC | 1.06% | $7.4M | Jun 30, 2026 | full (1,176 positions) |
| CET Central Securities Corp Taxable Bonds | Johnson & Johnson | 478160104 | EC | 0.97% | $17.8M | Jun 30, 2026 | full (33 positions) |
| GLV Clough Global Dividend & Income Fund Global Equity | Johnson & Johnson | 478160104 | EC | 0.85% | $796K | Jul 31, 2026 | full (104 positions) |
| ADX Adams Diversified Equity Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | 0.79% | $26.1M | Jun 30, 2026 | full (108 positions) |
| THQ abrdn Healthcare Opportunities Fund Healthcare | JOHNSON & JOHNSON | 478160BV5 | DBT | 0.77% | $8.1M | Jun 30, 2026 | full (109 positions) |
| CHW Calamos Global Dynamic Income Fund Taxable Bonds | Johnson & Johnson | 478160104 | EC | 0.64% | $5.4M | Jul 31, 2026 | full (750 positions) |
| GDV Gabelli Dividend & Income Trust U.S. Equity | JOHNSON & JOHNSON | 478160104 | EC | 0.64% | $21.6M | Jun 30, 2026 | full (729 positions) |
| CGO Calamos Global Total Return Fund Multi-Asset | Johnson & Johnson | 478160104 | EC | 0.64% | $1.3M | Jul 31, 2026 | full (704 positions) |
| THW abrdn World Healthcare Fund Healthcare | JOHNSON & JOHNSON | 478160BV5 | DBT | 0.63% | $4.4M | Jun 30, 2026 | full (131 positions) |
| ACV Virtus Diversified Income & Convertible Fund Convertible Securities | JOHNSON & JOHNSON | 478160104 | EC | 0.57% | $2.2M | Jul 31, 2026 | full (281 positions) |
| ECAT BlackRock ESG Capital Allocation Term Trust U.S. Equity | Johnson & Johnson | 478160104 | EC | 0.50% | $8.3M | Jun 30, 2026 | full (1,193 positions) |
| ETV Eaton Vance Tax-Managed Buy-Write Opportunities Fund Covered Call / Option Income | Johnson & Johnson | 478160104 | EC | 0.38% | $7.1M | Jun 30, 2026 | full (147 positions) |
| BCAT BlackRock Capital Allocation Term Trust U.S. Equity | Johnson & Johnson | 478160104 | EC | 0.36% | $6.1M | Jun 30, 2026 | full (1,148 positions) |
| AIO Virtus Artificial Intelligence & Technology Opportunities Fund Technology | JOHNSON & JOHNSON | 478160104 | EC | 0.33% | $3.5M | Jul 31, 2026 | full (101 positions) |
| GAB Gabelli Equity Trust U.S. Equity | JOHNSON & JOHNSON | 478160104 | EC | 0.20% | $4.8M | Jun 30, 2026 | full (709 positions) |
| GCV Gabelli Convertible & Income Securities Fund Convertible Securities | JOHNSON & JOHNSON | 478160104 | EC | 0.08% | $76.2K | Jun 30, 2026 | full (121 positions) |
| MMT Aberdeen Multi-Market Income Fund Taxable Bonds | JOHNSON & JOHNSON | XS3005215689 | DBT | 0.04% | $315K | Jul 31, 2026 | full (875 positions) |
| GOF Guggenheim Strategic Opportunities Fund Multi-Asset | JOHNSON & JOHNSON | 478160104 | EC | 0.00% | $17.1K | May 29, 2026 | full (1,841 positions) |
| BRW Saba Capital Income & Opportunities Fund U.S. Equity | Johnson & Johnson | 478160104 | EC | -0.01% | $-43.8K | Jul 31, 2026 | full (1,143 positions) |
Matching position names
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.